Retrospective analysis of 35 patients with acinic cell carcinoma of the parotid gland

J Oral Maxillofac Surg. 1998 Apr;56(4):440-3. doi: 10.1016/s0278-2391(98)90708-x.

Abstract

Purpose: This retrospective study evaluated data pertaining to the history, symptoms, treatment, and prognosis of a series of patients treated for acinic cell carcinoma (ACC).

Patients and methods: Data were based on the records of 35 patients. Follow-up was done by analyzing their records and contacting the referring doctors.

Results: In 71% of the ACC patients, painful swelling of the lateral region of the face was the main symptom. Facial paralysis occurred in 11% of cases before treatment. Tumor recurrence after therapy was noted in 42% of cases. Highly differentiated ACC was the most frequent histologic subtype (74%). The grade of differentiation of the tumor was decisive for the prognosis. Highly differentiated ACC had a better prognosis (2 years overall survival, 100%; 5 years overall survival, 83%; 10 years overall survival, 50%) than lowly differentiated tumors (2 years overall survival, 70%; 5 years overall survival, 50%; 10 years overall survival, 30%).

Conclusion: ACC is a rare tumor located mainly in the parotid gland that is characterized by some special attributes. Surgery is the therapy of choice. Prognosis depends mainly on the histologic subtype.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Acinar Cell / mortality
  • Carcinoma, Acinar Cell / pathology*
  • Carcinoma, Acinar Cell / therapy
  • Female
  • Follow-Up Studies
  • Humans
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Parotid Neoplasms / mortality
  • Parotid Neoplasms / pathology*
  • Parotid Neoplasms / therapy
  • Prognosis
  • Radiotherapy, Adjuvant
  • Retrospective Studies
  • Survival Rate